Because both platforms indicated that the pancreas contained higher levels of GABRP, we took advantage of our pancreatic cancer CFPAC-1 cells to test whether GABRP played an indispensable role in pancreatic cancer progression. Here, GABRP is linked to pancreatic neoplasm.